Siltuximab - Latest Advances

Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease.

Journal: Journal of chemotherapy (Florence, Italy)

Published: August 06, 2025

Treatment of Idiopathic Multicentric Castleman's Disease With Sequential Thalidomide-Cyclophosphamide-Prednisone After Siltuximab:Report of One Case.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: July 24, 2025

Complications and Management of Idiopathic Multicentric Castleman Disease.

Journal: HCA healthcare journal of medicine

Published: July 11, 2025

Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers.

Journal: Transplantation and cellular therapy

Published: July 06, 2025

CSF IL-6 in children with neuroinflammatory conditions.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: June 13, 2025

Sequential treatment with siltuximab and tocilizumab for childhood idiopathic multicentric Castleman disease: a case report

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Published: June 04, 2025

Network toxicology, molecular docking, and molecular dynamics simulations revealed the effects of carbendazim on bone metabolism and identified potential treatment drugs.

Journal: Computers in biology and medicine

Published: May 06, 2025

The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease.

Journal: American journal of hematology

Published: April 14, 2025

Idiopathic Multicentric Castleman's Disease Presenting with Chorioretinal Undulation: A Case Report.

Journal: Ocular immunology and inflammation

Published: March 18, 2025

Expert Perspective: Diagnosis and Treatment of Castleman Disease.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 16, 2025

Repurposing Antidiabetic Drugs for Gangrene: A Mendelian Randomization and Text Mining Study.

Journal: International journal of medical sciences

Published: January 24, 2025

Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy.

Journal: Frontiers in immunology

Published: January 20, 2025

Filters

Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease.

Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease.

Treatment of Idiopathic Multicentric Castleman's Disease With Sequential Thalidomide-Cyclophosphamide-Prednisone After Siltuximab:Report of One Case.

Treatment of Idiopathic Multicentric Castleman's Disease With Sequential Thalidomide-Cyclophosphamide-Prednisone After Siltuximab:Report of One Case.

Complications and Management of Idiopathic Multicentric Castleman Disease.

Complications and Management of Idiopathic Multicentric Castleman Disease.

Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers.

Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers.

CSF IL-6 in children with neuroinflammatory conditions.

CSF IL-6 in children with neuroinflammatory conditions.

Sequential treatment with siltuximab and tocilizumab for childhood idiopathic multicentric Castleman disease: a case report

Sequential treatment with siltuximab and tocilizumab for childhood idiopathic multicentric Castleman disease: a case report

Network toxicology, molecular docking, and molecular dynamics simulations revealed the effects of carbendazim on bone metabolism and identified potential treatment drugs.

Network toxicology, molecular docking, and molecular dynamics simulations revealed the effects of carbendazim on bone metabolism and identified potential treatment drugs.

The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease.

The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease.

Idiopathic Multicentric Castleman's Disease Presenting with Chorioretinal Undulation: A Case Report.

Idiopathic Multicentric Castleman's Disease Presenting with Chorioretinal Undulation: A Case Report.

Expert Perspective: Diagnosis and Treatment of Castleman Disease.

Expert Perspective: Diagnosis and Treatment of Castleman Disease.

Repurposing Antidiabetic Drugs for Gangrene: A Mendelian Randomization and Text Mining Study.

Repurposing Antidiabetic Drugs for Gangrene: A Mendelian Randomization and Text Mining Study.

Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy.

Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy.